We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Biochemical Markers Affected by Adiposity in Children

By LabMedica International staff writers
Posted on 02 Jan 2020
Print article
Image: Biochemical markers in blood samples are affected by adiposity in children (Photo courtesy of Photo Tom Mallinson).
Image: Biochemical markers in blood samples are affected by adiposity in children (Photo courtesy of Photo Tom Mallinson).
Pediatric or childhood obesity is the most prevalent nutritional disorder among children and adolescents worldwide. Approximately 43 million individuals are obese, 21%–24% children and adolescents are overweight, and 16%–18% of individuals have abdominal obesity.

The prevalence of pediatric obesity is increasing worldwide and strongly associates with metabolic abnormalities, including inflammation, insulin resistance and dyslipidemia. A recent study assessed the influence of three measures of adiposity on levels of routinely assessed biochemical markers in apparently healthy children and adolescents.

Specialists in Pediatric Laboratory Medicine at the Hospital for Sick Children, Toronto, ON, Canada) and their colleagues compared data on more than 1,300 Canadian children and adolescents, ranging from 5 to 19 years of age. Body mass index (BMI) values ranged from 13.4 to 65, although the majority of the participants were considered of normal weight, defined as from the 3rd to 85th percentile; 286 were overweight, and 136 were obese. The 97th percentile was the threshold for obesity. The influence of adiposity on 35 biochemical markers were examined.

The scientists reported that the most affected biomarkers were liver enzymes, lipids, and inflammatory markers, among them alanine aminotransferase, apolipoprotein B, complement factors C3 and C4, cholinesterase, high-sensitivity C-reactive protein, gamma-glutamyl transferase, haptoglobin, high-density lipoprotein (HDL) cholesterol, iron, transferrin, triglycerides, and uric acid. After adjusting for age and sex, these markers were significantly elevated according to BMI, highest among children with obesity. One exception was iron, which was decreased with overweight or obesity. Uric acid showed especially pronounced associations with increasing BMI. In both male and female participants, levels averaged 237 μmol/L, 261 μmol/L, and 270 μmol/L in normal weight, overweight, and obese children, respectively.

Victoria Higgins, PhD, the first author of the study, said, “We performed the first comprehensive analysis of the effect of obesity on routine blood tests in a large community population of children and found that almost 70% of the blood tests studied were affected. As clinical decisions are often guided by normative ranges based on a large healthy population, understanding how and which routine blood tests are affected by obesity is important to correctly interpret blood test results.”

The authors concluded that excess adiposity significantly influences circulating levels of routinely assessed laboratory markers, most notably liver enzymes, lipids/lipoproteins, inflammatory markers and uric acid, in children and adolescents. While it is unknown whether altered biochemical marker levels in subjects with overweight/obesity reflect health or indolent disease, clinicians should be aware of the effect of weight status on several laboratory tests. The study was published on December 17, 2019 in the Journal of Clinical Endocrinology & Metabolism.

Related Links:
Hospital for Sick Children

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.